Farmacosmo Statements
CO
Data from Farmacosmo`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
EUR - Euro
Last reporting period:
30 Jun, 2023
Next reporting period:
27 Dec, 2023
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
—
Farmacosmo Income Statement
B
M
EUR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
36.725
14.3 %
100
34.563
94.1
2.162
76.9 %
5.9
—
0
2.266
6.2
3.693
172.2 %
10.1
-1.531
-1035.8 %
-4.2
-0.419
-1.1
0
0.001
-1.949
-427 %
-5.3
0.151
0.4
-1.73
-505.6 %
-4.7
-0.05
34.677
32.118
1.6 %
100
30.896
96.2
1.222
-44.3 %
3.8
—
0
0.946
2.9
1.357
30.4 %
4.2
-0.135
-111.7 %
-0.4
-0.235
-0.7
—
0
-0.37
-139.6 %
-1.2
-0.084
-0.3
-0.286
-145.7 %
-0.9
-0.008
37.642
31.599
112.7 %
100
29.407
93.1
2.192
80.7 %
6.9
—
0
0.931
2.9
1.041
118.8 %
3.3
1.151
56.2 %
3.6
-0.218
-0.7
—
0
0.933
44.9 %
3
0.308
1
0.625
45.7 %
2
0.019
33.46
14.853
—
100
13.641
91.8
1.213
—
8.2
—
0
0.399
2.7
0.476
—
3.2
0.737
—
5
-0.093
-0.6
—
0
0.644
—
4.3
0.215
1.4
0.429
—
2.9
0.013
33.46